Eduardo Kleer, MD
Urology · Ypsilanti, MINPI 1831195304
Payments from drug & device makers
Across 23 payments — averaging $89.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Procept Biorobotics Corporation$1K
- Coloplast$252
- Novocure Inc.$163
- Tempus AI, Inc$123
- Terumo Medical Corporation$113
- Richard Wolf Medical Instruments Corp.$67
- plus $195 from 6 others
What the payments were for
- Travel & lodging$75436%
- Food & beverage$1,27762%
- Education$352%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Procept Biorobotics Corporation | 8 | $1,154 |
| Coloplast | 3 | $252 |
| Novocure Inc. | 1 | $163 |
| Tempus AI, Inc | 1 | $123 |
| Terumo Medical Corporation | 1 | $113 |
| Richard Wolf Medical Instruments Corp. | 1 | $67 |
| Boston Scientific | 2 | $58 |
| AstraZeneca | 1 | $35 |
| Olympus America Inc. | 1 | $30 |
| Dornier Medtech America, Inc | 1 | $28 |
| Laborie Medical Technologies Corp. | 2 | $25 |
| EDAP Technomed Inc | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AQUABEAM SYSTEM$870
- Azur CX Detachable$227
- Optune$163
- ANGIO-SEAL$113
- AquaBeam Robotic System$102
How this compares
$2,067 in reported general payments places this provider in the 45th percentile of 400 urology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 500 | $14,371 |
| Finasteride | 337 | $6,815 |
| Tadalafil | 72 | $6,795 |
| Oxybutynin Chloride ErOxybutynin Chloride | 99 | $3,762 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 76 | $2,892 |
| Testosterone | 14 | $1,084 |
| Terazosin Hcl | 32 | $991 |
| Solifenacin Succinate | 17 | $860 |
| Testosterone Cypionate | 20 | $773 |
| Bicalutamide | 21 | $700 |
| Cephalexin | 77 | $533 |
| Oxybutynin Chloride | 55 | $463 |
| Dutasteride | 20 | $453 |
| Gentamicin Sulfate | 15 | $286 |
| Doxazosin Mesylate | 15 | $236 |
Paid to pharmacies, not to this prescriber.
Other urology in Ypsilanti
- Jason HafronWest Bloomfield$9.9M
- Ashok ReddySterling Heights$4.9M
- Kenneth KernenTroy$3.4M
- James PeabodyDetroit$2.1M
- William RobertsAnn Arbor$973K
- Adam GadzinskiRoyal Oak$727K
- William JohnstonLivonia$675K
- Kenneth PetersRoyal Oak$590K
- Khurshid GhaniAnn Arbor$550K
- Richard BennettRoyal Oak$368K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.